NeuroGenesis

Cell therapies for neurodegenerative diseases

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Technologies
Company Founded Year
Company Number of Employees
NeuroGenesis
02/09/2022
NeuroPharmacology | NeuroBioTechnology
Biotechnology & Biopharmaceutical
Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis)
Biochemical: pharmacological drugs (Developing drugs)
01/01/2019

NeuroGenesis is a clinical-stage biotechnology company.
We are advancing innovative cell therapies via our propriety NEURALyzed CELL™ platform to combat neurodegenerative diseases